Haemostatix
Latest round
- Series C
Last raised
- Oct 2012
Total raised
- $1.3M
Investors
- 7
About Haemostatix
Haemostatix Ltd.Founded in 2003 and headquartered in Nottingham, UK, Haemostatix Ltd. specializes in creating advanced hemostatic solutions. The company was acquired by Ergomed PLC in May 2016 for an initial consideration of GBP 8 million, with a contingent consideration of GBP 20 million.Haemostatix specializes in the development and commercialization of innovative hemostatic products designed to address a range of bleeding disorders and surgical needs. Their core product offerings include advanced topical hemostats and surgical adjuncts that promote rapid blood clotting during medical procedures. These products utilize proprietary formulations enhancing the body's natural coagulation processes, reducing surgical complications and improving patient outcomes.4 for the year 2023.Haemostatix is focused on launching new hemostatic products and expanding its market presence in regions such as North America and Asia by 2025.
Who invested in Haemostatix
7 investors across 1 round
See all investors in Haemostatix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Oct 1, 2012
Amount
$1.3M
Investors
Questions about Haemostatix
Who invested in Haemostatix?
Haemostatix has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Haemostatix raised?
Haemostatix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Haemostatix last raise money?
Haemostatix's most recent round on record is a Series C, in Oct 2012.
What does Haemostatix do?
Haemostatix is a biotechnology company.
Where is Haemostatix headquartered?
Haemostatix is headquartered in Nottingham, UK.
Which VCs invest in companies like Haemostatix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Haemostatix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Haemostatix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.